Analysis | The Technology 202: Big Tech went big on lobbying spending – and privacy advocates are concerned

Brasil Notícia Notícia

Analysis | The Technology 202: Big Tech went big on lobbying spending – and privacy advocates are concerned
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 washingtonpost
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

Analysis: Big Tech went big on lobbying spending in Washington – and privacy advocates are concerned

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

washingtonpost /  🏆 95. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Analysis | The Technology 202: Apple's Tim Cook wants Congress to rein in data brokersAnalysis | The Technology 202: Apple's Tim Cook wants Congress to rein in data brokersAnalysis: Apple's Tim Cook wants Congress to rein in data brokers
Consulte Mais informação »

Nancy Pelosi's very big accusation against the White HouseNancy Pelosi's very big accusation against the White HouseSpeaker Nancy Pelosi canceled a planned trip to visit troops in Afghanistan Friday, after -- her office alleged in a statement -- the White House leaked the details of the congressional delegation's commercial plane travel.
Consulte Mais informação »

Defense and tech stocks are the big winners of Trump's first 2 years in officeDefense and tech stocks are the big winners of Trump's first 2 years in officeIt's been two years since Donald Trump was inaugurated as president of the United States. In that time, defense and tech stocks, have blown everybody out of the water.
Consulte Mais informação »

Facebook is the most 'vulnerable' big tech firm facing disruption, top VC saysFacebook is the most 'vulnerable' big tech firm facing disruption, top VC saysThe privacy scandals that have hit Facebook have made it the most 'vulnerable' large technology firm when it comes to the potential to be disrupted, a top VC told CNBC at Davos.
Consulte Mais informação »

A Big, Fatty Opportunity for Big PharmaA Big, Fatty Opportunity for Big PharmaThe next multibillion-dollar therapeutic area for drug companies may be fatty liver disease, but there are a few practical hurdles to overcome first.
Consulte Mais informação »



Render Time: 2025-03-05 04:17:35